Evaluation of Calorie Content of an All-natural Cane Sugar and Botanical Extract Sweetener: Studies in Wistar Rats

Sajan P.G.^1, , Rohith T.¹, Martin Tower² and Prathap H.D.¹

¹R&D Division, Trulit Herbals, Vishweshwaranagar, Mysuru-570008, India

²Dendera Natural Health LLC, 6750 N, Fort Lauderdale, FL 33309, USA

Cite this paper:
Sajan P.G., Rohith T., Martin Tower and Prathap H.D.. Evaluation of Calorie Content of an All-natural Cane Sugar and Botanical Extract Sweetener: Studies in Wistar Rats. American Journal of Food and Nutrition. 2020; 8(3):54-60. doi: 10.12691/ajfn-8-3-1

Abstract

The purpose of the study was to evaluate the caloric content and biochemical effects of an all-natural cane sugar/botanical extract sweetener in comparison to reference glucose in Wistar rats. A total of 24 male Wistar rats aged 6-7 weeks, weighing 148-188 grams, free from disease, and possessing a functional health status were chosen for the study. The animals were divided into four sets and allocated to different treatment groups using a randomized block design. For the study, the test and reference substances were administered orally at approximately one-hour intervals from Day 8 until the end of the treatment period. A greater than 50% reduction (58.7%) of liver adenosine triphosphate (ATP) levels (a proxy for caloric content) was observed for the test item (TI) treatment group compared to the reference glucose group. In the preliminary oral glucose tolerance test (OGTT), treatment with TI at a dose of 5.8 g/kg bodyweight considerably decreased the normal post-prandial rise in serum glucose levels. Other biochemical parameters such as cholesterol, triglycerides, LDL, and VLDL also decreased in the test item high dose group as compared to the normal control (NC). The current study confirms a significant reduction in calories (>50%) and blood glucose levels in Wistar rats when cane sugar is combined with a formulation of botanical extracts. Based on these results, we feel that all-natural TI has potential as a reduced-calorie, low glycemic index (GI) alternative to standard sucrose and can be a valuable dietary aid in the fight against the global obesity epidemic and its associated metabolic disorders.

Keywords:
diabetes calorie Glycemic index liver ATP Wistar rats

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	World Health Organization Obesity and Overweight. Fact Sheet, 2008. Available: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
[2]	McNamara, J.M., Houston, A.I., Higginson, A.D., “Costs of foraging predispose animals to obesity-related mortality when food is constantly abundant”. PLoS One, Vol. 10(11): e0141811, 2015.
[3]	Johnson, R.J., Sánchez-Lozada, L.G., Andrews, P., Lanaspa, M.A., “Perspective: a historical and scientific perspective of sugar and its relation with obesity and diabetes”. Advance Nutrition, vol. 8, 412-22, 2017.
[4]	Kramer, C.K., Zinman, B., Retnakaran, R., “Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis”. Annals of Internal Medicine, vol. 159, 758-769, 2013.
[5]	Spiegelman, B.M., Flier, J.S., “Obesity and the regulation of energy balance”. Cell, vol. 104, 531-543, 2001.
[6]	Hummel, E., Witting, F., Schneide,r K., Gebhardt, N., Hoffmann, I., “The complex interaction of causing and resulting factors of overweight/obesity. Increasing the understanding of the problem and deducing requirements for prevention strategies”. Wissensschaft & Forschung, vol. 60, 2-7, 2012.
[7]	Briefel, R.R., Johnson, C.L., “Secular trends in dietary intake in the United States”. Annual Review of Nutrition, vol. 24, 401-31, 2004.
[8]	Nielsen, S.J., Siega-Riz, A.M., Popkin, B.M., “Trends in energy intake in U.S. between 1977 and 1966: Similar shifts seen across age groups”. Obesity Research, vol. 10, no. 5, 370-378, 2002.
[9]	Morenga, L.T., Mallard, S., Mann, J., “Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies”. BMJ Clincial Research, vol. 346:e7492, 2013.
[10]	Atkinson, F.S., Foster-Powell, K., Brand-Miller, J.C., “International tables of glycemic index and glycemic load values”. Diabetes Care, vol. 31, 2281-3, 2008.
[11]	Rippe, J.M., Angelopoulos, T.J., “Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know?”. Advance Nutrition, vol. 4, 236-245, 2013.
[12]	Kahn, R., Sievenpiper, J.L., “Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? We have, but the pox on sugar is overwrought and overworked”. Diabetes Care, vol. 37, 957-62, 2014.
[13]	Havel, P.J., “Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism”. Nutrition Reviews, 63, 133-57, 2005.
[14]	Stanhope, K.L., Have, l P., “Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose or high-fructose corn syrup”. American Journal of Clinical Nutrition, vol. 8, 1733S-1737S, 2008
[15]	Malik, V.S., Sculze, M.B., Hu F.B., “Intake of sugar-sweetened beverages and weight gain: a systematic review”. American Journal of Clinical Nutrition, vol. 84, no. 2, 274-288, 2006.
[16]	Malik, V.S., Willett, W.C., Hu F.B., “Sugar-sweetened beverages and BMI in children and adolescents: reanalyses of a meta analysis”. American Journal of Clinical Nutrition, vol. 89, no. 1, 438-439, 2009. 2009; 89(1): 438-439.
[17]	Montonen, J., Jarvinen, R., Knekt, P., Heliovaara, M., Reunanen, A., “Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence”. Journal of Nutirion vol. 137, no. 6, 1447-1454, 2007.
[18]	Matthias, B.S, Joann, E.M., David, S.L., Graham, A.C., Meir, J.S., Walter, C.W., Frank, B.H., “Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women”. Journal of Americal Medical Association, vol. 292, 927-934, 2004.
[19]	John, P.B., “Dietary fructose and metabolic syndrome and diabetes”. Journal of Nutrition, vol. 139, no. 6, 1263S-1268S, 2009.
[20]	Anastasia, S., Kieron, R., B Robert, A. B., “Metabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat”. European Journal of Nutrition, vol. 51, 445-454, 2012.
[21]	Defronzo, R.A., “Banting Lecture: from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus”. Diabetes, vol. 58, 773-95, 2009.
[22]	Nolan, C.J., Damm, P., Prentki, M., “Type 2 diabetes across generations: from pathophysiology to prevention and management”. Lancet, vol. 378, 169-81, 2011.
[23]	Corkey, B.E., “Banting Lecture: Hyperinsulinemia: cause or consequence?”. Diabetes vol. 61, 4-13, 2012.
[24]	Kaur, B., Ranawana, V., The, A.L., Henry, C.J.K., “The impact of a low glycemic index (GI) breakfast and snack on daily blood glucose profiles and food intake in young Chinese adult males”. Journal of Clinical & Translational Endocrinolgy, vol. 2, no. 3, 92-98, 2015.
[25]	Miller, J.B., Hayne, S., Petocz, P., Colagiuri, S., “Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials”. Diabetes Care, vol. 26, no.8, 2261-2267, 2003.
[26]	Brand-Miller, J.C., Holt, S.H.A., Pawlak, D.B., McMillan, J., “Glycemic index and obesity”. American Journal of Clinical Nutrition, vol. 76, no. 1, 281-285, 2002.
[27]	Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., Ren, G., Ning, G., “Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine”. Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 7, 2559-2565, 2008.
[28]	Yin, J., Xing, H., Ye J., “Efficacy of berberine in patients with type 2 diabetes mellitus”. Metabolism, vol. 57, no. 5, 712-717, 2008.
[29]	Cheng, Z., Guo, S., Copps, K., Dong, K.X., Kollipara, R., Rodgers, J.T., “Foxo1 integrates insulin signalling with mitochondrial function in the liver”. Nature medicine, vol. 15, no. 11, 1307-1311, 2009.
[30]	Ming Zhang, Li Chen, “Berberine in type 2 diabetes therapy: a new perspective for an old antidiarrheal drug?:. Acta Pharmaceutica Sinica B, vol. 2, bno. 4, 379-386, 2012.
[31]	Daisy, P., Eliza, J., Farook, K.A.M., “A novel dihydroxy gymnemic triacetate isolated from Gymnemasylvestre possessing normoglycemic and hypolipidemic activity on STZ-induced diabetic rats”. Journal of Ethnopharmacolgy, vol. 126, 339-344, 2009.